Stereotactic Ablative Radiotherapy Before Resection to Avoid Delay for Early-stage Lung Cancer or Oligometastases During the COVID-19 Pandemic

Stereotactic Ablative Radiotherapy Before Resection to Avoid Delay for Early-stage Lung Cancer or Oligometastases During the COVID-19 Pandemic

header-info

Preliminary surgical and pathological results of the SABR-BRIDGE protocol indicate that adopting stereotactic ablative radiotherapy as a bridge to surgery results in successful and well-tolerated treatment for patients with early-stage presumed or biopsy-proven lung malignancy during operating room closures.

 

Access the full article to read more here.